Cortactin Modulates RhoA Activation and Expression of Cip/Kip Cyclin-Dependent Kinase Inhibitors To Promote Cell Cycle Progression in 11q13-Amplified Head and Neck Squamous Cell Carcinoma Cells

REFERENCES

• Abukhdeir, A. M., and B. H. Park. 2008. P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev. Mol. Med. 10:e19.
   PubMedGoogle Scholar
• Alt, J. R., A. B. Gladden, and J. A. Diehl. 2002. p21Cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277:8517–8523.
   PubMed Web of Science ®Google Scholar
• Bain, J., L. Plater, M. Elliott, N. Shpiro, C. J. Hastie, H. McLauchlan, I. Klevernic, J. S. Arthur, D. R. Alessi, and P. Cohen. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408:297–315.
   PubMed Web of Science ®Google Scholar
• Bowden, E. T., M. Barth, D. Thomas, R. I. Glazer, and S. C. Mueller. 1999. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18:4440–4449.
   PubMedGoogle Scholar
• Bryce, N. S., E. S. Clark, J. L. Leysath, J. D. Currie, D. J. Webb, and A. M. Weaver. 2005. Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr. Biol. 15:1276–1285.
   PubMedGoogle Scholar
• Caldon, C. E., R. J. Daly, R. L. Sutherland, and E. A. Musgrove. 2006. Cell cycle control in breast cancer cells. J. Cell Biochem. 97:261–274.
   PubMed Web of Science ®Google Scholar
• Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193–199.
   PubMed Web of Science ®Google Scholar
• Cheng, M., P. Olivier, J. A. Diehl, M. Fero, M. F. Roussel, J. M. Roberts, and C. J. Sherr. 1999. The p21(Cip1) and p27(Kip1) CDK “inhibitors” are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583.
   PubMed Web of Science ®Google Scholar
• Clark, E. S., B. Brown, A. S. Whigham, A. Kochaishvili, W. G. Yarbrough, and A. M. Weaver. 2009. Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 28:431–444.
   PubMed Web of Science ®Google Scholar
• Clark, E. S., and A. M. Weaver. 2008. A new role for cortactin in invadopodia: regulation of protease secretion. Eur. J. Cell Biol. 87:581–590.
   PubMedGoogle Scholar
• Clark, E. S., A. S. Whigham, W. G. Yarbrough, and A. M. Weaver. 2007. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67:4227–4235.
   PubMed Web of Science ®Google Scholar
• Courjal, F., M. Cuny, J. Simony-Lafontaine, G. Louason, P. Speiser, R. Zeillinger, C. Rodriguez, and C. Theillet. 1997. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res. 57:4360–4367.
   PubMed Web of Science ®Google Scholar
• Croft, D. R., and M. F. Olson. 2006. The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Mol. Cell. Biol. 26:4612–4627.
   PubMed Web of Science ®Google Scholar
• Daly, R. J. 2004. Cortactin signalling and dynamic actin networks. Biochem. J. 382:13–25.
   PubMed Web of Science ®Google Scholar
• Edlund, S., M. Landstrom, C. H. Heldin, and P. Aspenstrom. 2002. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol. Biol. Cell 13:902–914.
   PubMed Web of Science ®Google Scholar
• Gibcus, J. H., M. F. Mastik, L. Menkema, G. H. de Bock, P. M. Kluin, E. Schuuring, and J. E. van der Wal. 2008. Cortactin expression predicts poor survival in laryngeal carcinoma. Br. J. Cancer 98:950–955.
   PubMed Web of Science ®Google Scholar
• Gupton, S. L., K. Eisenmann, A. S. Alberts, and C. M. Waterman-Storer. 2007. mDia2 regulates actin and focal adhesion dynamics and organization in the lamella for efficient epithelial cell migration. J. Cell Sci. 120:3475–3487.
   PubMed Web of Science ®Google Scholar
• Hofman, P., C. Butori, K. Havet, V. Hofman, E. Selva, N. Guevara, J. Santini, and E. Van Obberghen-Schilling. 2008. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status. Br. J. Cancer. 98:956–964.
   PubMed Web of Science ®Google Scholar
• Huang, C., J. Liu, C. C. Haudenschild, and X. Zhan. 1998. The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J. Biol. Chem. 273:25770–25776.
   PubMed Web of Science ®Google Scholar
• Hui, R., D. H. Campbell, C. S. Lee, K. McCaul, D. J. Horsfall, E. A. Musgrove, R. J. Daly, R. Seshadri, and R. L. Sutherland. 1997. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 15:1617–1623.
   PubMed Web of Science ®Google Scholar
• Kamura, T., T. Hara, S. Kotoshiba, M. Yada, N. Ishida, H. Imaki, S. Hatakeyama, K. Nakayama, and K. I. Nakayama. 2003. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. Natl. Acad. Sci. U. S. A. 100:10231–10236.
   PubMed Web of Science ®Google Scholar
• Kamura, T., T. Hara, M. Matsumoto, N. Ishida, F. Okumura, S. Hatakeyama, M. Yoshida, K. Nakayama, and K. I. Nakayama. 2004. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat. Cell Biol. 6:1229–1235.
   PubMed Web of Science ®Google Scholar
• Kim, M. S., S. L. Li, C. N. Bertolami, H. M. Cherrick, and N. H. Park. 1993. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res. 13:1405–1413.
   PubMed Web of Science ®Google Scholar
• Kitagawa, M., H. Higashi, H. K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J. Kato, K. Segawa, E. Yoshida, S. Nishimura, and Y. Taya. 1996. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15:7060–7069.
   PubMed Web of Science ®Google Scholar
• LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847–862.
   PubMed Web of Science ®Google Scholar
• Lai, F. P., M. Szczodrak, J. M. Oelkers, M. Ladwein, F. Acconcia, S. Benesch, S. Auinger, J. Faix, J. V. Small, S. Polo, T. E. Stradal, and K. Rottner. 2009. Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases. Mol. Biol. Cell 20:3209–3223.
   PubMed Web of Science ®Google Scholar
• Lai, J. M., S. Wu, D. Y. Huang, and Z. F. Chang. 2002. Cytosolic retention of phosphorylated extracellular signal-regulated kinase and a Rho-associated kinase-mediated signal impair expression of p21Cip1/Waf1 in phorbol 12-myristate-13-acetate-induced apoptotic cells. Mol. Cell. Biol. 22:7581–7592.
   PubMedGoogle Scholar
• Liu, H. S., H. H. Lu, M. T. Lui, E. H. Yu, W. Shen, Y. P. Chen, K. W. Chang, and H. F. Tu. 2009. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Oral Oncol. 45:1032–1036.
   PubMedGoogle Scholar
• Luo, C., H. Pan, M. Mines, K. Watson, J. Zhang, and G. H. Fan. 2006. CXCL12 induces tyrosine phosphorylation of cortactin, which plays a role in CXC chemokine receptor 4-mediated extracellular signal-regulated kinase activation and chemotaxis. J. Biol. Chem. 281:30081–30093.
   PubMed Web of Science ®Google Scholar
• Luo, M. L., X. M. Shen, Y. Zhang, F. Wei, X. Xu, Y. Cai, X. Zhang, Y. T. Sun, Q. M. Zhan, M. Wu, and M. R. Wang. 2006. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res. 66:11690–11699.
   PubMed Web of Science ®Google Scholar
• Mammoto, A., S. Huang, K. Moore, P. Oh, and D. E. Ingber. 2004. Role of RhoA, mDia, and ROCK in cell shape-dependent control of the Skp2-p27kip1 pathway and the G1/S transition. J. Biol. Chem. 279:26323–26330.
   PubMed Web of Science ®Google Scholar
• Musgrove, E. A., L. J. Hunter, C. S. Lee, A. Swarbrick, R. Hui, and R. L. Sutherland. 2001. Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27Kip1 association with cyclin E-Cdk2. J. Biol. Chem. 276:47675–47683.
   PubMed Web of Science ®Google Scholar
• Olson, M. F., H. F. Paterson, and C. J. Marshall. 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394:295–299.
   PubMed Web of Science ®Google Scholar
• Ormandy, C. J., E. A. Musgrove, R. Hui, R. J. Daly, and R. L. Sutherland. 2003. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78:323–335.
   PubMed Web of Science ®Google Scholar
• Patel, A. S., G. L. Schechter, W. J. Wasilenko, and K. D. Somers. 1998. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16:3227–3232.
   PubMed Web of Science ®Google Scholar
• Pateras, I. S., K. Apostolopoulou, K. Niforou, A. Kotsinas, and V. G. Gorgoulis. 2009. p57KIP2: “Kip”ing the cell under control. Mol. Cancer Res. 7:1902–1919.
   PubMed Web of Science ®Google Scholar
• Paulsen, R. D., and K. A. Cimprich. 2007. The ATR pathway: fine-tuning the fork. DNA Repair (Amst.) 6:953–966.
   PubMedGoogle Scholar
• Rodrigo, J. P., D. Garcia-Carracedo, L. A. Garcia, S. Menendez, E. Allonca, M. V. Gonzalez, M. F. Fresno, C. Suarez, and J. M. Garcia-Pedrero. 2009. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J. Pathol. 217:516–523.
   PubMed Web of Science ®Google Scholar
• Rodrigo, J. P., L. A. Garcia, S. Ramos, P. S. Lazo, and C. Suarez. 2000. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin. Cancer Res. 6:3177–3182.
   PubMedGoogle Scholar
• Rothschild, B. L., A. H. Shim, A. G. Ammer, L. C. Kelley, K. B. Irby, J. A. Head, L. Chen, M. Varella-Garcia, P. G. Sacks, B. Frederick, D. Raben, and S. A. Weed. 2006. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res. 66:8017–8025.
   PubMed Web of Science ®Google Scholar
• Sahai, E., T. Ishizaki, S. Narumiya, and R. Treisman. 1999. Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol. 9:136–145.
   PubMedGoogle Scholar
• Sahai, E., M. F. Olson, and C. J. Marshall. 2001. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20:755–766.
   PubMed Web of Science ®Google Scholar
• Schuuring, E. 1995. The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes—a review. Gene 159:83–96.
   PubMed Web of Science ®Google Scholar
• Shang, X., Y. T. Zhou, and B. C. Low. 2003. Concerted regulation of cell dynamics by BNIP-2 and Cdc42GAP homology/Sec14p-like, proline-rich, and GTPase-activating protein domains of a novel Rho GTPase-activating protein, BPGAP1. J. Biol. Chem. 278:45903–45914.
   PubMed Web of Science ®Google Scholar
• Sutterluty, H., E. Chatelain, A. Marti, C. Wirbelauer, M. Senften, U. Muller, and W. Krek. 1999. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:207–214.
   PubMed Web of Science ®Google Scholar
• Swarbrick, A., C. S. Lee, R. L. Sutherland, and E. A. Musgrove. 2000. Cooperation of p27Kip1 and p18INK4c in progestin-mediated cell cycle arrest in T-47D breast cancer cells. Mol. Cell. Biol. 20:2581–2591.
   PubMedGoogle Scholar
• Tehrani, S., N. Tomasevic, S. Weed, R. Sakowicz, and J. A. Cooper. 2007. Src phosphorylation of cortactin enhances actin assembly. Proc. Natl. Acad. Sci. U. S. A. 104:11933–11938.
   PubMed Web of Science ®Google Scholar
• Timpson, P., D. K. Lynch, D. Schramek, F. Walker, and R. J. Daly. 2005. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor. Cancer Res. 65:3273–3280.
   PubMed Web of Science ®Google Scholar
• Timpson, P., A. S. Wilson, G. M. Lehrbach, R. L. Sutherland, E. A. Musgrove, and R. J. Daly. 2007. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. Cancer Res. 67:9304–9314.
   PubMed Web of Science ®Google Scholar
• Tsvetkov, L. M., K. H. Yeh, S. J. Lee, H. Sun, and H. Zhang. 1999. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661–664.
   PubMed Web of Science ®Google Scholar
• Vidal, C., B. Geny, J. Melle, M. Jandrot-Perrus, and M. Fontenay-Roupie. 2002. Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood 100:4462–4469.
   PubMed Web of Science ®Google Scholar
• Walker, I. G., R. W. Yatscoff, and R. Sridhar. 1977. Hydroxyurea: induction of breaks in template strands of replicating DNA. Biochem. Biophys. Res. Commun. 77:403–408.
   PubMedGoogle Scholar
• Wang, W., L. Chen, Y. Ding, J. Jin, and K. Liao. 2008. Centrosome separation driven by actin-microfilaments during mitosis is mediated by centrosome-associated tyrosine-phosphorylated cortactin. J. Cell Sci. 121:1334–1343.
   PubMedGoogle Scholar
• Weaver, A. M. 2008. Cortactin in tumor invasiveness. Cancer Lett. 265:157–166.
   PubMed Web of Science ®Google Scholar
• Weber, J. D., W. Hu, S. C. Jefcoat, Jr., D. M. Raben, and J. J. Baldassare. 1997. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272:32966–32971.
   PubMed Web of Science ®Google Scholar
• Welsh, C. F. 2004. Rho GTPases as key transducers of proliferative signals in g1 cell cycle regulation. Breast Cancer Res. Treat 84:33–42.
   PubMed Web of Science ®Google Scholar
• Zhang, S., Q. Tang, F. Xu, Y. Xue, Z. Zhen, Y. Deng, M. Liu, J. Chen, S. Liu, M. Qiu, Z. Liao, Z. Li, D. Luo, F. Shi, Y. Zheng, and F. Bi. 2009. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors. Mol. Cancer Res. 7:570–580.
   PubMedGoogle Scholar